Longeveron LGVN
NASDAQ LGVN
$2.59 -0.10 (-3.72%)
At close: Oct 1, 2026 · 4:00 PM EDT

Longeveron (LGVN) Deferred Taxes (2020 - 2023)

Updated

Longeveron's Deferred Taxes was $60,000 in Q2 2023, compared with -$15,000 a year earlier.

Analysis

Longeveron (LGVN) Deferred Taxes (2020 - 2023) Analysis & Trends

On a trailing twelve-month basis, Longeveron's Deferred Taxes was -$311,000 through Jun 30, 2023; for FY2022, it was -$307,000.

  • In earlier years, Deferred Taxes was -$188,000 in FY2021 and $532,000 in FY2020.
  • The Q2 2023 figure marks the highest quarterly Deferred Taxes since Q2 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -479.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -195.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -544.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -398.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -291.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -587.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -1.32 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Longeveron 8.14 Mn -31.66 Mn 182,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 60,000.00
Mar 31, 2023 -50,000.00
Jun 30, 2022 -15,000.00
Mar 31, 2022 -306,000.00
Dec 31, 2021 4,000.00
Sep 30, 2021 28,000.00
Jun 30, 2021 155,000.00
Mar 31, 2021 -375,000.00
Dec 31, 2020 232,000.00
Sep 30, 2020 -202,000.00
Jun 30, 2020 339,000.00
Mar 31, 2020 163,000.00
API Access

Longeveron Deferred Taxes API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=deferred-taxes&ticker=LGVN&period=max&api_key=YOUR_API_KEY